SCHEMBL8285289

SCHEMBL8285289

COC(=O)/C=C/c1cncc2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 1/20 0.37
CDK8 P49336 1/20 0.37
NFE2L2 Q16236 1/20 0.36
IP6K1 Q92551 1/20 0.35
IP6K3 Q96PC2 1/20 0.35
IP6K2 Q9UHH9 1/20 0.35
KDM4E B2RXH2 3/20 0.34
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MLYCD O95822 2/20 0.34
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
GAA P10253 2/20 0.33
HPGD P15428 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC10 Q969S8 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33
HTT P42858 2/20 0.33
TP53 P04637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286473 0.90 GSK3B (0.36) CCNCCDK8KMT2ASMN1; SMN2GAA
SCHEMBL8287251 0.82 GAA (0.36) KDM4EKMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL5872140 0.80 HDAC1 (0.37) CCNCCDK8IP6K1IP6K3IP6K2
SCHEMBL5872137 0.80 HDAC1 (0.37) CCNCCDK8IP6K1IP6K3IP6K2
SCHEMBL8286163 0.79 BRAF (0.40) KDM4EKMT2AALDH1A1MAPTGAA
SCHEMBL8285273 0.78 KDM4E (0.36) NFE2L2IP6K1IP6K3IP6K2KDM4E
SCHEMBL8287117 0.78 KDM4E (0.46) NFE2L2IP6K1IP6K3IP6K2KDM4E
SCHEMBL8287991 0.78 GAA (0.39) SMN1; SMN2ALDH1A1MAPTGAAHPGD
SCHEMBL8287214 0.78 GAA (0.44) KDM4EKMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL8286174 0.77 BRAF (0.39) KDM4EKMT2ASMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed